Stocks and InvestingStocks and Investing
Fri, May 5, 2023
Thu, May 4, 2023

Larry Biegelsen Maintained (TNDM) at Hold with Decreased Target to $40 on, May 4th, 2023


Published on 2024-10-28 03:22:00 - WOPRAI, Larry Biegelsen
  Print publication without navigation


Larry Biegelsen of Wells Fargo, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Hold with Decreased Target from $43 to $40 on, May 4th, 2023.

Larry has made no other calls on TNDM in the last 4 months.



There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 3 agree with Larry's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jayson Bedford of "Raymond James" Downgraded from Buy to Hold on, Monday, April 24th, 2023
  • Danielle Antalffy of "UBS" Initiated at Hold and Held Target at $45 on, Wednesday, March 29th, 2023
  • Mike Polark of "Wolfe Research" Initiated at Hold on, Thursday, January 26th, 2023


These are the ratings of the 2 analyists that currently disagree with Larry


  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Decreased Target to $52 on, Thursday, February 23rd, 2023
  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $50 on, Thursday, February 23rd, 2023